期刊文献+

血管内皮生长因子与胃癌抗血管生成治疗进展

原文传递
导出
作者 吴志刚
出处 《北京医学》 CAS 2006年第6期367-369,共3页 Beijing Medical Journal
  • 相关文献

参考文献19

  • 1Zetter BR.Angioenesis and tumor metastasis.Annu Rev Med,1998,49:407.
  • 2Neufeld G,Cohen T,Gengrinovitch S,et al.Vascular endothelial growth factor (VEGF) and its receptors.FASEB J,1999,13:9.
  • 3Ferrara N,Davis-Smyth T.The biology of vascular endothelial growth factors.Endocr Rev,1997,18:4-5.
  • 4Takagi H,Otani A,Koyama S,et al.Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF):amechanism contributing to VEGF-induced angigenesis.Proc Natl Acad Sci USA,2002,99:383-388.
  • 5Gondi CS,Lakka SS,Yanamandra N,et al.Expression of antisens uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion,tumor growth,and angiogenesis.Oncogene,2003,22:5967-5975.
  • 6Dumont DJ,Jussila L,Taipale J,et al.Cardiovascular failure in mouse embryos deficient in VEGF receptor-3.Science (Washington DC),1998,282:946-949.
  • 7Partanen TA,Alitalo K,Miettinen H.Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor-3 in 185 vascular tumors.Cancer(Phila),1999,86:2406-2412.
  • 8Duff SE,Li C,Jeziorska M,et al.Vascular endothelial growth factors C and D and lymphangiogensis in gastrointestinal tract mailignancy.Br J Cancer,2003,89:426-431.
  • 9Takahashi R,Tanaka S,Kitadai Y,et al.Expession of vascular endothelial growth factor and angiogenesis in gastrointestinal atromal tumor of the stomach.Oncology,2003,64:266-278.
  • 10周烨,朱慰祺,师英强,施达仁.血管内皮生长因子和抑癌基因p53在胃癌中的表达及其临床意义[J].中国癌症杂志,2003,13(1):9-12. 被引量:10

二级参考文献12

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1380
  • 2Martin Hu, Filipe MJ, Morris R, et al. p53 expression and prog nosis in gastric carcinoma [ J ]. Int J Cancer, 1993,50 (6): 859-862.
  • 3Saito H, Tsujitani S, Kondo A, et al. Expression of vascular en dothelial growth factor correlates with hematogenous recurrence in gastric carcinoma [ J ]. Surgery, 1999,125 (2): 195-201
  • 4Aas T, Borresen AL, Geisler S, et al. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients[J]. Nat Med,1996,2(5): 811-814.
  • 5Maeda K, Ogawa M, Chung YS, et al. Overexpression of p53 associated with tumor angiogenesis, tumor cell proliferation, and prognosis in gastric carcinoma[ J]. Oncol Rep, 1997,4(3 ): 765- 768.
  • 6Flejou JF, Fratio V, Muzeau F, et al. P53 abnormalities in ade nocarcinoma of the gastric cardia and antrum [ J ]. Mol Pathol, 1999,52(5 ), 263-268.
  • 7Kakeji Y, Korenaga D, Tsujitani S, et al. Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes[J]. Br J Cancer,1993,67(3 ): 589-593.
  • 8Mandriota SJ, Seghezzi G, Vassalli JD, et al. Vascular endothe lial growth factor increases urokinase receptor expression in vas cular endothelial cells[J]. J Biol Chem, 1995,271 ( 17 ): 9709- 9716.
  • 9Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 andv-Src exert opposing influence on human vascular endothelial growth factor gene expression [ J ]. Cancer Res, 1995,55 ( 24 ): 6161-6165.
  • 10Kieser A, Weich HA, Brandner G, et al. Mutant p53 potentiates protein kinase-C induction of vascular endothelial growth factorexpression [ J ]. Oncogene, 1994,9 (4): 963-969.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部